17 June 2026 – In the frame of the ICPerMed Strategic Working Group on Internationalisation, a webinar will be organised on 25 June 2026 from 15:00 to 16:30 CEST. Dr. Lawrence P. Petalidis, Director for Partnerships at Digital Health Solutions, the Digital and AI arm of M42 Health, Abu Dhabi, will present the work and successes of M42.
M42 – To deliver world-class patient-centric care enabled by advanced technologies and innovative solutions in the United Arab Emirates
M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialised, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.
Established in 2023, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 27 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.
Dr. Lawrence P. Petalidis
Trained as a biochemist and neurobiologist, Lawrence was awarded the Gwyneth Pretty endowed scholarship for this PhD from Cambridge University researching molecular oncology and the application of early artificial neuron networks on human brain tumour transcriptomics and biomarker discovery.
Over the last 21 years Lawrence has moved from biomedical research to commercial, innovation, strategy, business and strategic partnership roles across universities, two NGOs, four startup accelerators, startups, government and multinational companies. Whilst in London he led the setup of what is widely considered as one of the most successful NHS innovation programmes and was also is a founding member of the digital health.London accelerator.
Previously advisor for innovation and research for the Department of Health Abu Dhabi, Lawrence specialises in cross-disciplinary opportunity development, strategy and execution. His work in the UAE over the last 5 years has mainly focused on transformative B2G programmes including the Abu Dhabi Biobank, a global first deployment of liquid biopsy screening, genomics and digital health. He is currently Director for Partnerships and Alliances at Digital Health Solutions, the Digital and AI arm of M42 Health, Abu Dhabi. Lawrence is a grant assessor for the South African Medical Research Council and a WHO foresight expert working group member.
This is the sixth event of a series of webinars with the aim to overall increase the awareness about Personalised Medicine and to share information about activities and successes in the field.